Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of active ingredients for central nervous system (CNS) drugs. Its structure supports the creation of compounds with enhanced metabolic stability and bioavailability due to the presence of the trifluoromethoxy group. Commonly employed in medicinal chemistry for optimizing lead compounds in drug discovery programs targeting neurological disorders. Also utilized in the preparation of analogs for structure-activity relationship (SAR) studies.